Paul Horstmeier Health Catalyst, Inc. (HCAT) insider trading activity

Paul Horstmeier is Chief Operating Officer of Health Catalyst, Inc.. Currently has a direct ownership of 204,880 shares of HCAT, which is worth approximately $1.59 Million. The most recent transaction as insider was on Mar 22, 2023, when has been sold 50,000 shares (Common Stock) at a price of $4.42 per share, resulting in proceeds of $221,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 205K

0% 3M change

0% 12M change

Total Value Held $1.59 Million

Paul Horstmeier Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 22 2023	BUY Exercise of conversion of derivative security	$221,000 $4.42 p/Share	50,000 Added 19.62%	204,880 Common Stock
Mar 01 2023	SELL Payment of exercise price or tax liability	$63,790 $14.29 p/Share	4,464 Reduced 2.8%	154,880 Common Stock
Dec 01 2022	SELL Payment of exercise price or tax liability	$165,724 $10.65 p/Share	15,561 Reduced 8.9%	159,344 Common Stock
Sep 01 2022	SELL Payment of exercise price or tax liability	$33,309 $11.61 p/Share	2,869 Reduced 1.61%	174,905 Common Stock
Jun 01 2022	SELL Payment of exercise price or tax liability	$37,113 $14.6 p/Share	2,542 Reduced 1.41%	177,774 Common Stock
Apr 12 2022	SELL Open market or private sale	$131,033 $25.16 p/Share	5,208 Reduced 2.81%	180,316 Common Stock
Apr 12 2022	BUY Exercise of conversion of derivative security	$73,745 $14.16 p/Share	5,208 Added 2.73%	185,524 Common Stock
Mar 09 2022	SELL Open market or private sale	$595,543 $25.66 p/Share	23,209 Reduced 11.54%	177,834 Common Stock
Mar 09 2022	BUY Exercise of conversion of derivative security	$74,242 $15.84 p/Share	4,687 Added 2.28%	201,043 Common Stock
Mar 02 2022	SELL Payment of exercise price or tax liability	$13,105 $26.69 p/Share	491 Reduced 0.25%	196,356 Common Stock
Mar 01 2022	SELL Payment of exercise price or tax liability	$80,289 $26.63 p/Share	3,015 Reduced 1.53%	193,683 Common Stock
Mar 01 2022	BUY Grant, award, or other acquisition	-	3,164 Added 1.58%	196,847 Common Stock
Feb 24 2022	BUY Grant, award, or other acquisition	-	100,000 Added 33.7%	196,698 Common Stock
Feb 07 2022	SELL Open market or private sale	$313,578 $29.17 p/Share	10,750 Reduced 10.0%	96,698 Common Stock
Feb 07 2022	BUY Exercise of conversion of derivative security	$140,502 $13.07 p/Share	10,750 Added 9.09%	107,448 Common Stock
Jan 05 2022	SELL Open market or private sale	$398,072 $37.03 p/Share	10,750 Reduced 10.0%	96,698 Common Stock
Jan 05 2022	BUY Exercise of conversion of derivative security	$170,280 $15.84 p/Share	10,750 Added 9.09%	107,448 Common Stock
Dec 07 2021	SELL Open market or private sale	$100,000 $40.29 p/Share	2,482 Reduced 2.67%	90,635 Common Stock
Dec 06 2021	SELL Open market or private sale	$235,669 $38.87 p/Share	6,063 Reduced 6.11%	93,117 Common Stock
Dec 02 2021	SELL Payment of exercise price or tax liability	$388,499 $41.95 p/Share	9,261 Reduced 8.54%	99,180 Common Stock
Nov 05 2021	SELL Open market or private sale	$565,880 $52.64 p/Share	10,750 Reduced 9.02%	108,441 Common Stock
Nov 05 2021	BUY Exercise of conversion of derivative security	$170,280 $15.84 p/Share	10,750 Added 8.27%	119,191 Common Stock
Oct 05 2021	SELL Open market or private sale	$520,300 $48.4 p/Share	10,750 Reduced 9.02%	108,441 Common Stock
Oct 05 2021	BUY Exercise of conversion of derivative security	$170,280 $15.84 p/Share	10,750 Added 8.27%	119,191 Common Stock
Sep 07 2021	SELL Open market or private sale	$472,030 $54.9 p/Share	8,598 Reduced 7.35%	108,441 Common Stock

Paul Horstmeier

Chief Operating Officer

South Jordan, UT

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HCAT shares.

Notify only if

Value

Insider Trading

Get notified when an Health Catalyst, Inc. insider buys or sells HCAT shares.

Notify only if

Operation

Value

Type

News

Receive news related to Health Catalyst, Inc.

Track Activities on HCAT

Account